Small cell lung cancer: Clinical practice guidelines in oncology

Academic Article


  • Neuroendocrine tumors account for approximately 20% of lung cancers; most (≈15%) are small cell lung cancer (SCLC). These NCCN Clinical Practice Guidelines in Oncology for SCLC focus on extensive-stage SCLC because it occurs more frequently than limited-stage disease. SCLC is highly sensitive to initial therapy; however, most patients eventually die of recurrent disease. In patients with extensive-stage disease, chemotherapy alone can palliate symptoms and prolong survival in most patients; however, long-term survival is rare. Most cases of SCLC are attributable to cigarette smoking; therefore, smoking cessation should be strongly promoted. Copyright © 2013, JNCCN-Journal of the National Comprehensive Cancer Network.
  • Digital Object Identifier (doi)

    Author List

  • Kalemkerian GP; Akerley W; Bogner P; Borghaei H; Chow LQ; Downey RJ; Gandhi L; Ganti AKP; Govindan R; Grecula JC
  • Start Page

  • 78
  • End Page

  • 98
  • Volume

  • 11
  • Issue

  • 1